Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 28Observational 3Expanded_access 2

Sponsor

Cancer Type

Gastrointestinal 25Sarcoma 3CNS 1

Conditions

Gastrointestinal Stromal Tumors 2Neoplasm Metastasis 1Colorectal Neoplasms 1Advanced Gastrointestinal Stromal Tumor 1

Interventions

Blood Specimen Collection 14Surveys and Questionnaires 13Surgical Procedures, Operative 12Gene Expression Profiling 10Observation 7Amplified Fragment Length Polymorphism Analysis 7Polymerase Chain Reaction 6Drug Therapy 6Radiotherapy 5Microarray Analysis 5Immunohistochemistry 5Psychiatric Rehabilitation 4Imatinib Mesylate 4Base Sequence 4regorafenib 3Trabectedin 3Tissue Banks 3Therapeutics 3Sunitinib 3Specimen Handling 3Reverse Transcriptase Polymerase Chain Reaction 3Radiation 3Methods 3Magnetic Resonance Imaging 3Interviews as Topic 3Doxorubicin 3Biopsy 3ripretinib 2mifamurtide 2Watchful Waiting 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × regorafenib × Sarcoma × Clear all
NCT06321055 2025-05-20

An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States

Bayer

Completed
136 enrolled
GastrointestinalSarcoma

Advanced Gastrointestinal Stromal Tumor

NCT02106858 2023-07-24

StivargaPMS

Bayer

Completed
316 enrolled
GastrointestinalSarcoma

Neoplasm Metastasis, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT01933958 2022-04-01

Regorafenib Post-marketing Surveillance in Japan

Bayer

Completed
72 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡